Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05PCM
|
|||
| Former ID |
DIB004560
|
|||
| Drug Name |
Abrocitinib
|
|||
| Synonyms |
PF-04965842
Click to Show/Hide
|
|||
| Indication | Atopic dermatitis [ICD-11: EA80; ICD-10: L20] | Approved | [1] | |
| Lupus [ICD-11: 4A40; ICD-9: 710] | Phase 2 | [2] | ||
| Company |
Pfizer
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H21N5O2S
|
|||
| Canonical SMILES |
CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3
|
|||
| InChI |
1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)
|
|||
| InChIKey |
IUEWXNHSKRWHDY-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1622902-68-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 213871. | |||
| REF 2 | ClinicalTrials.gov (NCT02201524) Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.